HARRIS & HARRIS GROUP, INC. (NASDAQ:TINY) Files An 8-K Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.
issued a press release regarding the filing of its preliminary
proxy statement with the Securities and Exchange Commission. A
copy of this press release, along with the presentation
referenced therein, are attached hereto as Exhibits 99.1 and
99.2, respectively.
shall not be deemed to be filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the Exchange Act),
or otherwise subject to the liabilities of that section.
|
(a)
|
Not applicable.
|
|
(b)
|
Not applicable.
|
|
(c)
|
Not applicable.
|
|
(d)
|
Exhibits.
|
January 23, 2017
About HARRIS & HARRIS GROUP, INC. (NASDAQ:TINY)
Harris & Harris Group, Inc. is a non-diversified management investment company operating as a business development company. The Company specializes in making investments in companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences. The Company provides operational and management resources, and financial solutions to such companies. Its investment objective is to achieve long-term capital appreciation by making venture capital investments. It holds interest in various sectors, such as precision health and precision medicine, other BIOLOGY+ and active legacy. Its precision health and precision medicine includes medical technologies, digital technologies, genetic and biochemical technologies, and machine learning technologies. The Company holds interest in over eight portfolio companies that focus on the precision health and precision medicine market. HARRIS & HARRIS GROUP, INC. (NASDAQ:TINY) Recent Trading Information
HARRIS & HARRIS GROUP, INC. (NASDAQ:TINY) closed its last trading session 00.00 at 1.50 with 521,679 shares trading hands.
